MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test could spare some cancer patients unnecessary treatment
Disease control Recruiting nowThis trial is testing if a simple blood test can help doctors decide which patients need extra treatment after surgery for aggressive bladder cancer. The test looks for tiny pieces of cancer DNA in the blood. Patients with a positive test will receive immunotherapy drugs to try t…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Bladder cancer breakthrough? trial tests cutting treatment time by 75%
Disease control Recruiting nowThis large Phase 3 trial is testing whether a much shorter, more intense course of radiation (5 sessions) works as well as the standard longer course (20 sessions) for patients with muscle-invasive bladder cancer. All participants will also receive standard chemotherapy. The main…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Bladder-Saving combo could spare cancer patients major surgery
Disease control Recruiting nowThis study is testing whether a combination of radiation therapy and an immunotherapy drug (pembrolizumab) can help patients with muscle-invasive bladder cancer avoid having their bladder surgically removed. It is for patients whose tumors have shrunk significantly after initial …
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo offers hope to bladder cancer patients: keep your bladder, skip major surgery
Disease control Recruiting nowThis study is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can effectively treat muscle-invasive bladder cancer. The goal is to see if the drugs can shrink the tumor enough so that some patients can avoid having their bladder surgically remove…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Blood and urine tests aim to spot hidden bladder cancer before major surgery
Diagnosis Recruiting nowThis study is testing whether a combination of blood tests, urine tests, and a thorough bladder exam can better identify if muscle-invasive bladder cancer is still present before a patient has their bladder surgically removed. Researchers will enroll 92 patients with bladder canc…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC